9B75
Crystal structure of humanized 44H10 Fab Version 17
Summary for 9B75
Entry DOI | 10.2210/pdb9b75/pdb |
Descriptor | h44H10-V17 Antibody, heavy chain, h44H10-V17 Antibody, light chain, 1,2-ETHANEDIOL, ... (4 entities in total) |
Functional Keywords | antibody, humanized, immune system |
Biological source | Homo sapiens More |
Total number of polymer chains | 2 |
Total formula weight | 47131.91 |
Authors | Kassardjian, A.,Julien, J.P. (deposition date: 2024-03-27, release date: 2024-08-07, Last modification date: 2024-10-23) |
Primary citation | Kassardjian, A.,Ivanochko, D.,Barber, B.,Jetha, A.,Julien, J.P. Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. Antibodies, 13:-, 2024 Cited by PubMed Abstract: Reducing the immunogenicity of animal-derived monoclonal antibodies (mAbs) for use in humans is critical to maximize therapeutic effectiveness and preclude potential adverse events. While traditional humanization methods have primarily focused on grafting antibody Complementarity-Determining Regions (CDRs) on homologous human antibody scaffolds, framework regions can also play essential roles in antigen binding. Here, we describe the humanization of the pan-HLA-DR mAb 44H10, a murine antibody displaying significant involvement of the framework region in antigen binding. Using a structure-guided approach, we identify and restore framework residues that directly interact with the antigen or indirectly modulate antigen binding by shaping the antibody paratope and engineer a humanized antibody with affinity, biophysical profile, and molecular binding basis comparable to that of the parental 44H10 mAb. As a humanized molecule, this antibody holds promise as a scaffold for the development of MHC class II-targeting therapeutics and vaccines. PubMed: 39051333DOI: 10.3390/antib13030057 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.95 Å) |
Structure validation
Download full validation report